These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10551212)

  • 1. Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases.
    Ichikawa T; Federle MP; Grazioli L; Madariaga J; Nalesnik M; Marsh W
    Radiology; 1999 Nov; 213(2):352-61. PubMed ID: 10551212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: helical CT and MR imaging findings with clinical-pathologic comparison.
    Iannaccone R; Piacentini F; Murakami T; Paradis V; Belghiti J; Hori M; Kim T; Durand F; Wakasa K; Monden M; Nakamura H; Passariello R; Vilgrain V
    Radiology; 2007 May; 243(2):422-30. PubMed ID: 17356175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma in noncirrhotic liver: CT, clinical, and pathologic findings in 39 U.S. residents.
    Brancatelli G; Federle MP; Grazioli L; Carr BI
    Radiology; 2002 Jan; 222(1):89-94. PubMed ID: 11756710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Imaging findings of fibrolamellar hepatocellular carcinoma].
    Wang M; Cui Z; Yu G
    Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):128-30. PubMed ID: 11776854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrolamellar hepatocellular carcinoma: pre- and posttherapy evaluation with CT and MR imaging.
    Ichikawa T; Federle MP; Grazioli L; Marsh W
    Radiology; 2000 Oct; 217(1):145-51. PubMed ID: 11012437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma: the role of helical biphasic contrast-enhanced CT versus CT during arterial portography.
    Kanematsu M; Oliver JH; Carr B; Baron RL
    Radiology; 1997 Oct; 205(1):75-80. PubMed ID: 9314965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign hepatic nodules in Budd-Chiari syndrome: radiologic-pathologic correlation with emphasis on the central scar.
    Maetani Y; Itoh K; Egawa H; Haga H; Sakurai T; Nishida N; Ametani F; Shibata T; Kubo T; Tanaka K; Konishi J
    AJR Am J Roentgenol; 2002 Apr; 178(4):869-75. PubMed ID: 11906865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small (≤1-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging.
    Yu MH; Kim JH; Yoon JH; Kim HC; Chung JW; Han JK; Choi BI
    Radiology; 2014 Jun; 271(3):748-60. PubMed ID: 24588677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation.
    Earls JP; Theise ND; Weinreb JC; DeCorato DR; Krinsky GA; Rofsky NM; Mizrachi H; Teperman LW
    Radiology; 1996 Oct; 201(1):207-14. PubMed ID: 8816545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of hepatocellular carcinoma in patients with cirrhosis: MR imaging versus angiographically assisted helical CT.
    Kanematsu M; Hoshi H; Murakami T; Inaba Y; Kim T; Yamada T; Kato M; Yokoyama R; Nakamura H
    AJR Am J Roentgenol; 1997 Dec; 169(6):1507-15. PubMed ID: 9393154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver.
    Yamashita Y; Mitsuzaki K; Yi T; Ogata I; Nishiharu T; Urata J; Takahashi M
    Radiology; 1996 Jul; 200(1):79-84. PubMed ID: 8657948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma: CT and MR features after transcatheter arterial embolization and percutaneous ethanol injection.
    Bartolozzi C; Lencioni R; Caramella D; Falaschi F; Cioni R; DiCoscio G
    Radiology; 1994 Apr; 191(1):123-8. PubMed ID: 8134557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
    Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
    Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images.
    Kelekis NL; Semelka RC; Worawattanakul S; de Lange EE; Ascher SM; Ahn IO; Reinhold C; Remer EM; Brown JJ; Bis KG; Woosley JT; Mitchell DG
    AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
    De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
    Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrolamellar hepatocellular carcinoma--an atypical MR manifestation.
    Hui MS; Choi WM; Perng HL; Chen LK; Yang KC; Chen TJ
    Hepatogastroenterology; 1998; 45(20):514-7. PubMed ID: 9638440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The magnetic resonance of small hepatocarcinoma. A comparison with echography, computed tomography, digital angiography and computed tomography with lipiodol].
    De Santis M; Cristani A; Cioni G; Casolo A; Canossi G; Ventura E; Romagnoli R
    Radiol Med; 1992 Nov; 84(5):587-95. PubMed ID: 1335589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver.
    Holland AE; Hecht EM; Hahn WY; Kim DC; Babb JS; Lee VS; West AB; Krinsky GA
    Radiology; 2005 Dec; 237(3):938-44. PubMed ID: 16306035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of cancer cell differentiation in small hepatocellular carcinoma by computed tomography and magnetic resonance imaging.
    Amano S; Ebara M; Yajima T; Fukuda H; Yoshikawa M; Sugiura N; Kato K; Kondo F; Matsumoto T; Saisho H
    J Gastroenterol Hepatol; 2003 Mar; 18(3):273-9. PubMed ID: 12603527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early advanced hepatocellular carcinoma: evaluation of CT and MR appearance with pathologic correlation.
    Winter TC; Takayasu K; Muramatsu Y; Furukawa H; Wakao F; Koga H; Sakamoto M; Hirohashi S; Freeny PC
    Radiology; 1994 Aug; 192(2):379-87. PubMed ID: 8029401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.